ARK Genomic Revolution ETF (ARKG)
BATS: ARKG · Real-Time Price · USD
32.06
-0.47 (-1.44%)
At close: Jan 15, 2026, 4:00 PM EST
32.17
+0.11 (0.34%)
Pre-market: Jan 16, 2026, 4:21 AM EST
ARKG Holdings Information
ARKG is an equity ETF with a total of 35 individual holdings. The top holdings are Tempus AI stock at 8.81%, CRISPR Therapeutics AG at 8.37%, Twist Bioscience at 6.59%, Beam Therapeutics at 5.84%, and Personalis at 5.71%.
Total Holdings
35
Top 10 Percentage
58.65%
Asset Class
Equity
ETF Category
Health
Assets
1.33B
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TEM | Tempus AI, Inc. | 8.81% |
| 2 | CRSP | CRISPR Therapeutics AG | 8.37% |
| 3 | TWST | Twist Bioscience Corporation | 6.59% |
| 4 | BEAM | Beam Therapeutics Inc. | 5.84% |
| 5 | PSNL | Personalis, Inc. | 5.71% |
| 6 | GH | Guardant Health, Inc. | 5.34% |
| 7 | TXG | 10x Genomics, Inc. | 5.07% |
| 8 | ILMN | Illumina, Inc. | 4.41% |
| 9 | RXRX | Recursion Pharmaceuticals, Inc. | 4.34% |
| 10 | NTRA | Natera, Inc. | 4.17% |
| 11 | VCYT | Veracyte, Inc. | 3.43% |
| 12 | CDNA | CareDx, Inc. | 3.19% |
| 13 | ABSI | Absci Corporation | 2.97% |
| 14 | ADPT | Adaptive Biotechnologies Corporation | 2.86% |
| 15 | SDGR | Schrödinger, Inc. | 2.86% |
| 16 | NTLA | Intellia Therapeutics, Inc. | 2.64% |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 2.34% |
| 18 | BFLY | Butterfly Network, Inc. | 2.27% |
| 19 | NRIX | Nurix Therapeutics, Inc. | 2.23% |
| 20 | PACB | Pacific Biosciences of California, Inc. | 1.94% |
| 21 | WGS | GeneDx Holdings Corp. | 1.59% |
| 22 | PRME | Prime Medicine, Inc. | 1.58% |
| 23 | ARCT | Arcturus Therapeutics Holdings Inc. | 1.49% |
| 24 | CERS | Cerus Corporation | 1.35% |
| 25 | CMPS | COMPASS Pathways plc | 1.21% |
As of Jan 15, 2026